Palla Pharma Ltd
ASX:PAL
Palla Pharma Ltd
ASX:PAL
Price:
0.295 AUD
Market Closed
Updated:
May 21, 2024
Palla Pharma Ltd
Cost of Revenue
|
Palla Pharma Ltd
Cost of Revenue Peer Comparison
Comparables:
ADO
PIQ
CTE
GSS
E
EZZ
Competitive Cost of Revenue Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Cost of Revenue | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Palla Pharma Ltd
ASX:PAL
|
Cost of Revenue
-AU$23.2m
|
CAGR 3-Years
6%
|
CAGR 5-Years
-61%
|
CAGR 10-Years
N/A
|
|
|
Anteotech Ltd
ASX:ADO
|
Cost of Revenue
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Proteomics International Laboratories Ltd
ASX:PIQ
|
Cost of Revenue
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Cryosite Ltd
ASX:CTE
|
Cost of Revenue
-AU$4.9m
|
CAGR 3-Years
3%
|
CAGR 5-Years
-6%
|
CAGR 10-Years
-2%
|
|
|
Genetic Signatures Ltd
ASX:GSS
|
Cost of Revenue
-AU$9.8m
|
CAGR 3-Years
4%
|
CAGR 5-Years
-32%
|
CAGR 10-Years
N/A
|
|
E
|
EZZ Life Science Holdings Ltd
ASX:EZZ
|
Cost of Revenue
-AU$8.6m
|
CAGR 3-Years
13%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Palla Pharma Ltd's Cost of Revenue?
Cost of Revenue
-23.2m
AUD
-23.2m
AUD
Based on the financial report for Jun 30, 2021, Palla Pharma Ltd's Cost of Revenue amounts to -23.2m AUD.
What is Palla Pharma Ltd's Cost of Revenue growth rate?
Cost of Revenue CAGR 5Y
-61%
-61%
Over the last year, the Cost of Revenue growth was 23%. The average annual Cost of Revenue growth rates for Palla Pharma Ltd have been 6% over the past three years , -61% over the past five years .
You don't have any saved screeners yet
